share_log

复旦张江(01349)及子公司泰州复旦张江、上海溯源生物技术累计收到政府补助资金3113.63万元

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co. Ltd. (01349) and its subsidiary Taizhou Fudan-Zhangjiang and Shanghai Source Biotechnology have received a total of 31.1363 million yuan in government subsidies.

Zhitong Finance ·  Dec 30, 2024 17:29

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co. Ltd. (01349) announced that the company and its subsidiary Taizhou Fudan-Zhangjiang Pharmaceutical Co. Ltd. (hereinafter referred to as...)

According to the report from Zhitong Finance APP, Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co. Ltd. (01349) announced that the company and its subsidiary Taizhou Fudan-Zhangjiang Pharmaceutical Co. Ltd. (hereinafter referred to as "Taizhou Fudan-Zhangjiang") and Shanghai Origin Biotechnology Co., Ltd. have cumulatively received government subsidies amounting to 31.1363 million yuan from the beginning of the year to the date of this announcement. This amount includes the government subsidies received by the subsidiary Taizhou Fudan-Zhangjiang from the beginning of the year to June 18, 2024, totaling 16.2 million yuan.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment